75 related articles for article (PubMed ID: 14598588)
1. [Diagnostic implications of detecting antibodies to angiotensin-converting enzyme and its substrates].
Kostrikin DS; Panchenko ON; Miagkova MA; Stanislav ML; Kost OA; Nikol'skaia II; Pogozheva AV; Kiselev IP; Valuev DI
Klin Med (Mosk); 2003; 81(9):31-4. PubMed ID: 14598588
[TBL] [Abstract][Full Text] [Related]
2. [Autoantibodies to vasoactive peptides and angiotensin converting enzyme in patients with systemic diseases of the connective tissue].
Stanislav ML; Balabanova RM; Alekperov RT; Miagkova MA; Abramenko TV; Kiselev IP; Kost OA; Nikol'skaia II; Garats EV
Ter Arkh; 2001; 73(5):20-5. PubMed ID: 11517741
[TBL] [Abstract][Full Text] [Related]
3. [Bronchoconstriction in administration of ACE inhibitors].
Aleksandrov OV; Miagkova MA; Kondrashova TV
Klin Med (Mosk); 2002; 80(10):56-9. PubMed ID: 12471841
[TBL] [Abstract][Full Text] [Related]
4. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
6. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
[TBL] [Abstract][Full Text] [Related]
8. Development of an enzymatic assay for the detection of neutralizing antibodies against therapeutic angiotensin-converting enzyme 2 (ACE2).
Liao K; Sikkema D; Wang C; Lee TN
J Immunol Methods; 2013 Mar; 389(1-2):52-60. PubMed ID: 23298658
[TBL] [Abstract][Full Text] [Related]
9. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
10. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
11. Serum angiotensin converting enzyme level in bronchial asthma.
Mue S; Takahashi M; Ohmi T; Shibahara S; Yamauchi K; Fujimoto S; Okayama H; Takishima T
Ann Allergy; 1978 Jan; 40(1):51-7. PubMed ID: 74963
[TBL] [Abstract][Full Text] [Related]
12. [A prospective study on the cough mechanism induced by angiotensin-converting enzyme inhibitors in patients with hypertension].
Ye RJ; He QY; Gai J; Shang Y
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):581-4. PubMed ID: 15498266
[TBL] [Abstract][Full Text] [Related]
13. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
[TBL] [Abstract][Full Text] [Related]
14. Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.
Voors AA; van Geel PP; Oosterga M; Buikema H; van Veldhuisen DJ; van Gilst WH
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):130-4. PubMed ID: 15526248
[TBL] [Abstract][Full Text] [Related]
15. [Cough, bronchoconstriction and bronchial hyperreactivity in relation to treatment with angiotensin-converting enzyme].
Szmidt M; Minc P
Pol Merkur Lekarski; 1999 May; 6(35):281-5. PubMed ID: 10437403
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin in ischemia-reperfusion injury of the rat lung.
Nowak K; Weih S; Post S; Gebhard MM; Hohenberger P
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):513-22. PubMed ID: 18204165
[TBL] [Abstract][Full Text] [Related]
17. Changes of chymase, angiotensin converting enzyme and angiotensin II type 1 receptor expressions in the hamster heart during the development of heart failure.
Chen PM; Leng XG; Fan LL; Ma J; Wang YF; Chen LY
Chin Med J (Engl); 2005 Nov; 118(22):1886-92. PubMed ID: 16313843
[TBL] [Abstract][Full Text] [Related]
18. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
19. Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure.
Tang WH; Vagelos RH; Yee YG; Fowler MB
Am Heart J; 2004 Nov; 148(5):889-94. PubMed ID: 15523323
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
